Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
757 11 |
Ultima descărcare din IBN: 2023-05-21 00:21 |
Căutarea după subiecte similare conform CZU |
616.366-002-036.12-07-08:618.3 (1) |
Pathology of the digestive system. Complaints of the alimentary canal (1748) |
SM ISO690:2012 CERNEŢCHI, Olga, CEMORTAN, Maria, SAGAIDAC, Irina. Managementul terapeutic al colestazei intrahepatice de sarcină. In: Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos”, 2019, nr. 3(54), pp. 40-44. ISSN 1857-0461. DOI: https://doi.org/10.5281/zenodo.3525086 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţă, Inovare, Cultură şi Artă „Akademos” | ||||||
Numărul 3(54) / 2019 / ISSN 1857-0461 /ISSNe 2587-3687 | ||||||
|
||||||
DOI:https://doi.org/10.5281/zenodo.3525086 | ||||||
CZU: 616.366-002-036.12-07-08:618.3 | ||||||
Pag. 40-44 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Maternal outcome of intrahepatic cholestasis of pregnancy (ICP) is usually benign, with postpartum pruritus resolving, but with a major predisposition to ante-, intra- and post-partum haemorrhage, as a main cause of maternal morbidity and mortality. Besides that, ICP is associated with increased fetal morbidity and mortality, especially preterm birth, respiratory distress and stillbirth. The main option of the management of intrahepatic cholestasis of pregnancy is to improve maternal symptoms, to normalize the biochemical markers and to reduce risks for the fetus. Ursodeoxycholic acid is the best therapeutic agent available, with proven efficacy in decrease skin pruritus and restoring abnormal levels of serum bile acids and functional tests of liver. |
||||||
Cuvinte-cheie intrahepatic cholestasis of pregnancy, ursodeoxycholic acid, functional tests of liver, colestaza intrahepatică de sarcină, acidul ursodeoxicolic, teste funcționale ale ficatului |
||||||
|